Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base

Background: Current guidelines recommend discussion of adjuvant chemotherapy (AC) for stage II colon cancer (CC) with high-risk features despite lacking conclusive randomized trial data. We examined AC administration in this population and its effect on overall survival (OS) for available patient, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukkamalla, Shiva Kumar R., Huynh, Donny V., Somasundar, Ponnandai S., Rathore, Ritesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523086/
https://www.ncbi.nlm.nih.gov/pubmed/33042845
http://dx.doi.org/10.3389/fonc.2020.568417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523086/
https://www.ncbi.nlm.nih.gov/pubmed/33042845
http://dx.doi.org/10.3389/fonc.2020.568417

Ejemplares similares